Agnes Y. Y. Lee
Director of Thrombosis, Division of Hematology, University of British Columbia, Canada
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Agnes Y. Y. Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:34 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT01130025 · Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in CancerLEO Pharma · completed · Venous Thromboembolism · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:34 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.N Engl J Med · 20031,942 citationsRCR 49.4
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.N Engl J Med · 2019678 citationsRCR 31.6
- 491 citationsRCR 18.8
- Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.J Clin Oncol · 2005372 citationsRCR 9.1
- 281 citationsRCR 16.3
- Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.Circulation · 2012174 citationsRCR 5.3
- 89 citationsRCR 3.8
- What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients' Quality of Life?Value Health · 201880 citationsRCR 3.5
- Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial.Ann Intern Med · 201368 citationsRCR 2.5
- CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.BMC Cancer · 201361 citationsRCR 2.1